These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9554433)

  • 21. Clinical applications of ribozymes.
    Kiehntopf M; Esquivel EL; Brach MA; Herrmann F
    Lancet; 1995 Apr; 345(8956):1027-31. PubMed ID: 7723502
    [No Abstract]   [Full Text] [Related]  

  • 22. Ribozyme gene therapy for cancer nears clinical trials.
    Oncology (Williston Park); 1995 Nov; 9(11):1180, 1182. PubMed ID: 8703687
    [No Abstract]   [Full Text] [Related]  

  • 23. Function and biological applications of catalytic nucleic acids.
    Gaughan DJ; Whitehead AS
    Biochim Biophys Acta; 1999 Apr; 1445(1):1-20. PubMed ID: 10209254
    [No Abstract]   [Full Text] [Related]  

  • 24. Ribozyme therapy: RNA enzymes to the rescue.
    Jose AM
    Yale J Biol Med; 2002; 75(4):215-9. PubMed ID: 12784972
    [No Abstract]   [Full Text] [Related]  

  • 25. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.
    Yau EH; Butler MC; Sullivan JM
    Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral delivery and anti-HIV testing of hammerhead ribozymes.
    Cagnon L; Rossi J
    Methods Mol Biol; 1997; 74():451-7. PubMed ID: 9204460
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene therapy for HIV.
    Lever AM
    Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684
    [No Abstract]   [Full Text] [Related]  

  • 28. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.
    Taylor NR; Kaplan BE; Swiderski P; Li H; Rossi JJ
    Nucleic Acids Res; 1992 Sep; 20(17):4559-65. PubMed ID: 1408757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition of HIV replication by ribozyme strategy].
    Ohkawa J; Taira K
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1421-9. PubMed ID: 7568943
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical aspects of ribozymes as therapeutics in gene therapy.
    Looney D; Yu M
    Methods Mol Biol; 1997; 74():469-86. PubMed ID: 9204462
    [No Abstract]   [Full Text] [Related]  

  • 33. Ribozyme: a clinical tool.
    Khan AU
    Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribozymes enter clinical trials for HIV-1 treatment.
    Rowe PM
    Lancet; 1996 Nov; 348(9037):1302. PubMed ID: 8909386
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic applications of ribozymes and riboswitches.
    Mulhbacher J; St-Pierre P; Lafontaine DA
    Curr Opin Pharmacol; 2010 Oct; 10(5):551-6. PubMed ID: 20685165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meeting Report. Ribozymes: progress and prospects of catalytic RNA as therapeutic agents.
    Chrisey L; Rossi J; Sarver N
    Antisense Res Dev; 1991; 1(1):57-63. PubMed ID: 1822249
    [No Abstract]   [Full Text] [Related]  

  • 37. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.
    Sakamoto N; Wu CH; Wu GY
    J Clin Invest; 1996 Dec; 98(12):2720-8. PubMed ID: 8981917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribozymes as antiviral agents.
    Bartolomé J; Castillo I; Carreño V
    Minerva Med; 2004 Feb; 95(1):11-24. PubMed ID: 15041923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes.
    Prislei S; Buonomo SB; Michienzi A; Bozzoni I
    RNA; 1997 Jun; 3(6):677-87. PubMed ID: 9174101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.